PODD: Financial results · Company disclosure

Item 2.02. Results of Operations and Financial Condition. On November 4, 2026, Insulet Corporation (the “Company”) announced its financial results for the third quarter ended September 30, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Item 7.01. Regulation FD Disclosure On October 30, 2026, the Board of Directors of Insulet Corporation (the “Company”) authorized a stock repurchase program, pursuant to which the Company may purchase up to $1 billion of its outstanding common stock through December 31, 2028. The Company plans to allocate approximately $400 million of this program toward repurchases in the fourth quarter of 2026, using existing cash. Under the stock repurchase program, the Company may repurchase its common stock from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions and other considerations and in accordance with applicable federal securities laws and other legal requirements. The Company's repurchases may be executed using open market purchases, unsolicited or solicited privately negotiated transactions, an accelerated stock repurchase program, and/or a trading plan in compliance with Rule 10b5-1 promulgated under the Exc